CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

CVS Health plans to shed enrollment by more than 1 million members this year, mostly in Medicare Advantage and individual ...

BofA raised the firm’s price target on CVS Health (CVS) to $75 from $63 and keeps a Buy rating on the shares. Aetna can add $3-$4 per share of ...

CVS Health Corp (CVS) reports robust revenue growth and strategic advancements, while navigating financial pressures and ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, emphasizing recovery in ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...

Shares of CVS Health Corp. continued climbing premarket Thursday after a blockbuster session driven by stronger-than-expected ...

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, expectations were $0.914. Operator: Good morning and thank you all for ...

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...